Colorblindness, a condition that largely affects men, may be tied to a higher death risk for bladder cancer, according to a new study, a finding that invites sober consideration of how vision affects medical decision making.

The research adds to the argument that accurate recognition of warning signs can influence outcomes as surely as any surgical or pharmacological intervention.

Global statistics indicate that about 8 percent of men have some form of color vision deficiency, compared with roughly 0.5 percent of women, underscoring a substantial gender based prevalence gap.

That difference matters because color perception informs everyday tasks and health seeking behavior, including whether someone notices telltale signs like blood in the urine.

Here's What They're Not Telling You About Your Retirement

Indeed, color vision problems could cause individuals to miss blood in the urine, a critical early signal of bladder cancer that often triggers investigation and treatment when recognized promptly. When that signal is missed, delays in diagnosis often follow, and those delays can translate into worse outcomes for patients who were otherwise on a path to cure.

In the study published in Nature Health, researchers analyzed extensive health records and found that bladder cancer patients who are colorblind have a 52 percent higher mortality rate over twenty years than patients with normal vision.

That striking disparity highlights how practical barriers to detection, rather than the biology of cancer itself, can shape survival odds over time.

Because colorblind individuals may fail to recognize blood in the urine, they may delay seeking care, and that delay can permit the cancer to advance before intervention. Bladder cancer is about four times more common among men than women, which makes the potential impact of this gap particularly on point for men.

This Could Be the Most Important Video Gun Owners Watch All Year

Senior study author Ehsan Rahimy, M.D., adjunct clinical associate professor of ophthalmology at Stanford Medicine, said he is hopeful the study raises awareness not only for patients with colorblindness but for our colleagues who treat colorblind individuals. "hopeful this study raises some awareness, not only for patients with colorblindness, but for our colleagues who see these patients."

Dr. Douglas Lazzaro, a professor in NYU Langone's Department of Ophthalmology, says the inability to recognize the color red in this scenario is a "real risk." He warned that gaps in perception can affect timely diagnosis of bladder or kidney cancer.

"The patient, family and medical doctor should be made aware of this potential gap in diagnosis." He was not involved in the study, but the point stands that such a gap can delay care and affect outcomes.

"My guess is that many doctors may not be looking closely enough at the medical record to pick up on this eye problem, leading to delays in diagnosis as the patient may not be able to see the issue."

That observation highlights a practical duty for clinicians to review patient history with color vision in mind.

"While the issue may not be completely avoidable, Lazzaro suggested that it could be prevented if colorblind patients are aware of the risk and inform their doctors of their vision limitation."

The takeaway is that awareness paired with straightforward testing can reduce delays in diagnosis.

Don Railsback, an optometrist and CEO of Vision Care Direct in Kansas, agreed that people with known CVD and their clinicians should pay close attention.

"This is the kind of small detail in a medical history that can change how we counsel patients on the symptoms they should never ignore."

"The takeaway is simple: Don’t rely on color alone to detect a problem. Bladder cancer can present as painless bleeding, and if you ever suspect blood in your urine, you should alert your doctor."

Railsback, who was not part of the research, added that if the color of urine looks off, for example tea colored or unusually dark, the patient should be checked promptly.

Colorblindness doesn’t cause bladder cancer, but it may make the earliest warning sign easier to miss, he said. "The fix is awareness and simple testing, not fear."